Copyright © 2006, European Society of Cardiology
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility
aUniversity Leipzig-Heart Center Leipzig, Department of Cardiology, Leipzig, Germany
bDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
cInstitute of Anesthesiology and Operative Intensive Medicine; University Mannheim, Germany
dDepartment of Medicine III, Martin-Luther University Halle-Wittenberg, Halle, Germany
* Corresponding author. Universität Leipzig, Herzzentrum, Klinik für Innere Medizin / Kardiologie, Strümpellstrasse 39, D-04289 Leipzig, Germany. Tel.: +49 341 865 1671; fax: +49 341 865 1461. Email address: adav{at}medizin.uni-leipzig.de
Objective: In chronic heart failure (CHF) the myocardial expression of the inflammatory cytokine tumor necrosis factor alpha (TNF-
), which is thought to contribute to myocardial remodeling, was found to be increased. However, it is unknown whether the E3-ubiquitin ligases MAFbx and Murf-1 are involved in this remodeling process and whether their expression is regulated by TNF-.
Methods: Rats underwent ligation of the left coronary artery to induce CHF or were sham-operated. The expression of MAFbx/Murf-1 and troponin I was analyzed by RT-PCR and Western blotting in the non-infarcted area of the left ventricle. In cell culture experiments the potency of TNF- to stimulate Murf-1/MAFbx expression, the intracellular signaling pathway, and the involvement of the E3-ligases for the impairment of contractility were assessed.
Results: In CHF the myocardial expression of TNF- was elevated 3.1-fold as compared to control. This was associated with a 4.5-fold and 2.7-fold increase in MAFbx and Murf-1 expression, respectively. A positive correlation between TNF- and the expression of MAFbx or Murf-1 was evident. In neonatal rat cardiomyocytes, TNF- induced the expression of MAFbx through p38MAPK-dependent pathways, whereas the induction of Murf-1 required the activation of the p42/44 MAPK pathway. Exposure of cardiomyocytes to TNF- resulted in troponin I ubiquitinylation, subsequent degradation, and a decline in contractility. This was completely abrogated by siRNAs against Murf-1/MAFbx.
Conclusion: TNF-, which is increasingly expressed in CHF, induces troponin I degradation through a MAFbx/Murf-1-dependent pathway. This was associated with an impairment of contractility and might be one mechanism involved in the adverse remodeling process in CHF.
KEYWORDS Heart failure; Gene expression; Cytokines; Myocytes; Protein catabolism; Ubiquitin proteasome system
1 Both authors contributed equally to this work.
Time for primary review 18 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Mearini, C. Gedicke, S. Schlossarek, C. C. Witt, E. Kramer, P. Cao, M. D. Gomes, S. H. Lecker, S. Labeit, M. S. Willis, et al. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms Cardiovasc Res, November 18, 2009; (2009) cvp348v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Xie, S. Guo, Y. Fan, H. Zhang, D. Gu, and H. Li Atrogin-1/MAFbx Enhances Simulated Ischemia/Reperfusion-induced Apoptosis in Cardiomyocytes through Degradation of MAPK Phosphatase-1 and Sustained JNK Activation J. Biol. Chem., February 27, 2009; 284(9): 5488 - 5496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, and G. Schuler Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair Eur. Heart J., February 1, 2009; 30(3): 346 - 355. [Abstract] [Full Text] [PDF]
|
|